Different patterns of apoptosis of HL‐60 cells induced by cycloheximide and camptothecin

Journal of Cellular Physiology

Volumn 157, Issue 2, 1993, Pages 263-270

  Li, Jianping Gong Xun ^a   Darzynkiewicz, Zbigniew ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CYCLOHEXIMIDE; DNA TOPOISOMERASE; ENZYME INHIBITOR;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL STRAIN HL 60; CONTROLLED STUDY; DNA REPLICATION; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

APOPTOSIS; CAMPTOTHECIN; CELL CYCLE; CYCLOHEXIMIDE; ELECTROPHORESIS, AGAR GEL; FLOW CYTOMETRY; HUMAN; LEUKEMIA, PROMYELOCYTIC, ACUTE; S PHASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOSYLLYSINE CHLOROMETHYL KETONE; TUMOR CELLS, CULTURED;

EID: 0027386228     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041570208     Document Type: Article

References (32)

1. Apoptosis: The role of endonuclease
2. Inhibitors of proteases prevent endonucleolysis accompanying apoptotic cell death
3. o cells and is prevented by inhibitors of proteases
4. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c‐myc expression
5. Induction of TRPM‐2 gene in cells undergoing programmed death
6. Programmed cell death in the immune system
7. Effects of cycloheximide on B‐chronic lymphocytic leukaemic and normal lymphocytes in vitro: Induction of apoptosis
8. The cell cycle specific effects of tumor necrosis factor
9. Features of apoptotic cells measured by flow cytometry
10. Camptothecin, teniposide or 4′‐(9‐acridinylamino)‐3‐methane‐sulfon‐m‐anisidide but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in S phase of HL‐60 cells
11. Diverse effects of camptothecin, an inhibitor of topoisomerase I on the cell cycle of lymphocytic (L1210, MOLT‐4) and myelogenous (HL‐60, KG1) leukemia cells
12. Apoptotic cell death triggered by camptothecin or teniposide: The cell cycle specificity and effects of ionizing radiation
13. Drug‐target interactions: Only the first step in the commitment to a programmed cell death?
14. Genetic control of programmed cell death in the nematode C. elegans
15. DNA strand breaks occurring during apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors
16. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias
17. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays
18. The cell cycle related differences in susceptibility of HL‐60 cells to apoptosis induced by various antitumor agents
19. Apoptosis induced by anticancer drugs
20. Arrest of replication forks by drug‐stabilized topoisomerase I‐DNA cleavable complexes as a mechanism of cell killing by camptothecin
21. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in chinese hamster DC3F cells
22. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytostatic anticancer drugs. A cautionary note
23. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics
24. Inhibition of apoptosis (programmed cell death) in human leukemic HL‐60 cells by inhibition of RNA or protein synthesis
25. A restriction point for control of normal animal cell proliferation
26. Differential induction of apoptosis in undifferentiated and differentiated HL‐60 cells by DNA topoisomerase I and II inhibitors
27. Teniposide induces nuclear but not mitochondrial DNA degradation
28. Effects of inhibition of RNA or protein synthesis on CHO cell cycle progression
29. The biology of cell death in tumors
30. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
31. Cell death: The significance of apoptosis
32. A model for tumor cell killing by topoisomerase poisons